-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: GEN: Off label use - here we go again From: doctorjoe@aol.com Tue May 23 14:58:46 2006 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: Efrain Ramirez: "Re: ACOG meeting in DC" Previous message: Richard Chudacoff, MD: "Re: GEN: Off label use - here we go again" In reply to: Richard Chudacoff, MD: "Re: GEN: Off label use - here we go again" Next in thread: Henry Gregor: "Re: GEN: Off label use - here we go again" Reply: Henry Gregor: "Re: GEN: Off label use - here we go again" Guess you agree with Pastorek's Rule of the Universe: If it weren't for the sleazy lawyers, the lying doctors and the greedy insurance companies, the System would work just fine. Joe P. -----Original Message----- From: Richard Chudacoff, MD <rchudacoff@mylinuxisp.com> To: Multiple recipients of list OB-GYN-L <ob-gyn-l@dns.obgyn.net> Sent: Tue, 23 May 2006 14:17:40 -0500 Subject: Re: GEN: Off label use - here we go again Just another stooge for the legal industry. I'm getting sort of tired of fellow physicians thinking of ways to increase my risk for law suits. -- Richard Chudacoff, MD, FACOG -----Original Message----- From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net] On Behalf Of art fougner, md Sent: Tuesday, May 23, 2006 2:08 PM To: Multiple recipients of list OB-GYN-L Subject: Re: GEN: Off label use - here we go again Joe aspirin nor magnesium sulfate were approved by the FDA for common indications. art At Tue, 23 May 2006, doctorjoe@aol.com wrote: > >In medical school, we were taught the "off label use" theory with propranolol and hypertension (at least I was - I guess I'm dating myself). > >Now we have all sorts of examples of drugs used for nonindicated reasons (a good example for us has been terbutaline, or maybe now the calcium channel blockers). > >Have we been taught WRONG??? > >Off Label Drug Use is Often Not Supported by Hard Science > >A study published in the Archives of Internal Medicine finds that the practice of prescribing drugs for off label uses is putting patients at risk. These prescriptions often lack evidence of safety and effectiveness, which makes them potentially dangerous to consumers. A professor at Stanford University believes misinformation plays a role in off-label prescribing and urges patients to ask their doctor why before taking the drug. Sandra G. Boodman, The Washington Post 05/23/2006 > >Read Article: The Washington Post > >Joe P. -- art fougner, md "I drank what?" - Socrates Next message: Efrain Ramirez: "Re: ACOG meeting in DC" Previous message: Richard Chudacoff, MD: "Re: GEN: Off label use - here we go again" In reply to: Richard Chudacoff, MD: "Re: GEN: Off label use - here we go again" Next in thread: Henry Gregor: "Re: GEN: Off label use - here we go again" Reply: Henry Gregor: "Re: GEN: Off label use - here we go again"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Jul 2 04:43:47 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.